Trial Profile
Prospective, Multicentre, Placebo-controlled, Double-blind Interventional Study to Compare the Efficacy of Maintenance Treatment With Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Patients
Status:
Completed
Phase of Trial:
Phase III/IV
Latest Information Update: 25 Jul 2022
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Prednisone
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms SEMIRA
- Sponsors Roche
- 15 Jun 2019 Results determining whether GC tapering in the SEMIRA trial resulted in any cases of adrenal insufficiency presented at the 20th Annual Congress of the European League Against Rheumatism
- 15 Jun 2019 Results presented at the 20th Annual Congress of the European League Against Rheumatism
- 15 Jun 2019 Results presented at the 20th Annual Congress of the European League Against Rheumatism